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The complete amino acid sequence of protein B (= CAMP factor) of Streprococcus ugalucliae has been determined. The 
sequence data were obtained mainly by manual sequencing of peptides derived from digestion with lysyl-peptidase, clos- 
tripain and Staphylococcus aureus protease and by solid phase sequencing of cyanogen bromide fragments. The protein 
contains 226 amino acids and has an M, of 25 263. The sequence was compared with sequences of other Fc-binding 
proteins and partial sequence homology was found between protein B and the Fc-binding region of protein A. 
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1. INTRODUCTION 
Protein B (= CAMP factor) [I] is produced by 
most strains of Streptococcus agalactiae (group B 
streptococci) and was described first by Christie et 
al. [2] in 1944. The authors demonstrated that the 
‘CAMP factor’ lyses in a synergistic way 
sphingomyelinase-treated sheep erythrocytes. Pro- 
tein B has been purified recently and characterized 
as polypeptide with an apparent molecular mass of 
25 kDa and an isoelectric point of 8.9 [3]. 
The interaction of protein B with membranes 
has been studied in detail mainly with the effort to 
characterize its membrane damaging potential 
[4-61. Protein B is released from growing cultures 
[7] together with four satellite proteins, which are 
very similar in their isoelectric points, molecular 
masses and hydrophobicity [3]. Interestingly, pro- 
tein B is the only one active in synergistic 
hemolysis. 
Additionally a recent study has shown that pro- 
tein B belongs to the group of bacterial Fc-binding 
proteins [l] such as protein A of Staphylococcus 
aweus and the Fc-receptor proteins of a variety of 
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streptococci [S]. Unlike protein A [9] and the Fc- 
binding proteins of streptococci of group A, C and 
G [lo] protein B remains not cell wall associated, 
but is released to a large extend into the superna- 
tant during mid to late logarithmic growth phase 
[ill. 
In respect to the possible role of protein B in 
streptococcal pathogenicity the newly described 
Fc-binding property may be more important than 
the well known co-cytolytic activity of the CAMP 
factor which seems to be rather an epiphenomenon 
with little relevance in vivo. 
The complete amino acid sequence of protein B, 
presented in this paper, has been determined to ob- 
tain information on the structure/function rela- 
tionship of the protein and to compare the 
sequence with those of other Fc-binding proteins. 
2. MATERIALS AND METHODS 
2.1. Purification of protein B 
Protein B was purified from the culture supernatant of group 
B streptococci as described by Jiirgens et al. [3]. 
2.2. Sequence determination 
Sequence studies were performed with peptides prepared by 
digestion of intact protein B or subdigestion of protein B 
fragments with the following enzymes: clostripain (Sigma), 
lysyl-peptidase (Wako, Tokyo), Staphylococcus aureus pro- 
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tease (Miles) and thermolysin (Boehringer-Mannheim). In addi- 
tion, peptides obtained by cleavage with cyanogen bromide 
(CNBr) were used for sequence analysis. 
Peptides resulting from CNBr cleavage were isolated by gel 
filtration on a TSK 2000 SW column (7.5 x 600 mm) at a flow 
rate of 0.2 ml/min. Peptides were applied to the column in 6 M 
guanidinium hydrochloride in 0.1% trifluoroacetic acid and 
detected by their absorbance at 206 nm. All other peptides were 
isolated by reversed-phase HPLC on a Nucleosil 300 5 pm Cl8 
column (4 x 250 mm) using different gradients of O-80% 
acetonitrile in 0.1% trifluoroacetic acid. Peptides were eluted at 
a flow rate of 0.5 ml/min and detected by their absorbance at 
230 nm. For amino acid analysis peptides were hydrolysed in 
5.7 M HCl at 110°C for 20 h and the amino acid composition 
was determined on a HPLC system using o-phthaldialdehyde as 
derivatizing reagent [12]. 
Peptides were sequenced manually by the DABITUPITC 
(4’ -N,N’-dimethylaminoazobenzene-4’-isothiocyanate/phen- 
ylisothiocyanate) double-coupling method [13]. Larger peptides 
were also sequenced automatically with a solid-phase sequencer 
(LKB 4020) as described [14]. For determination of the C- 
terminal amino acids intact protein B was digested with carbox- 
ypeptidase P (Boehringer-Mannheim) and the released amino 
acids were quantitated by amino acid analysis. 
2.3. Computer analysis 
Hydrophobicity analysis was performed with the program 
HYDROP (M. Dzionara and B. Wittmann-Liebold, unpublish- 
ed) using the parameters of Kyte and Doolittle [15]. The amino 
acid sequence of protein B was compared with the sequences of 
Fc-binding proteins (protein A [16], protein G [17]) with the 
program ALIGN [18] on a VAX/VMX computer. 
3. RESULTS AND DISCUSSION 
3.1. Sequence determination 
The complete amino acid sequence of protein B 
is presented in fig. 1. The sequence was derived 
mainly by sequence analysis of the CNBr 
fragments and the fragments obtained by cleavage 
with lysyl-peptidase. These peptides were aligned 
by sequencing overlapping peptides from S. aureus 
protease and clostripain digestion. 
Sequencing of the N-terminal region was dif- 
ficult due to the accumulation of asparagine and 
glutamine residues and the absence of cleavage 
sites for more specific proteases, but was finally 
achieved by sequence analysis of smaller peptides 
produced by subdigestion of the N-terminal CNBr 
fragment with thermolysin. 
The C-terminal sequence of protein B was de- 
rived from sequence analysis of the C-terminal S. 
aureus protease peptide and from results of car- 
boxypeptidase P digestion. 
3.2. Characteristics of the sequence 
Protein B contains 226 amino acids and has a 
calculated M, of 25 263. This value is in good 
agreement with the apparent molecular masses of 
25 kDa and 23.5 kDa determined by Jiirgens [3] 
and Bernheimer [5], respectively. The amino acid 
composition as derived from the sequence is shown 
in table 1. With the exception of cysteine all com- 
mon amino acids were present and no unusual 
amino acids were found. The relative frequency of 
the amino acids detected either by amino acid 
analysis [5,19] or derived from the sequence is in 
good agreement. The small quantitative discrepan- 
cies found for individual amino acids may be ex- 
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Fig. 1. Amino acid sequence of protein B. CN, LYS, CL, V and 
TH indicate peptides derived from cleavage with cyanogen 
bromide, lysyl-peptidase, clostripain, Staphylococcus aureus 
V8 protease and thermolysin, respectively. 
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Table 1 
Amino acid composition of protein B 
Amino acid Residues in protein B 
Calculated from From 
sequence 
iI91 PI 
Asx 28 33 34 
Glx 29 29 29 
Val 29 24 25 
Thr 18 16 21 
Lys 23 18 20 
Leu 19 17 19 
Ala 20 20 17 
Ile 13 18 15 
Ser 10 11 12 
Arg 6 4 7 
Pro 6 6 6 
Phe 5 6 5 
Gly 12 10 5 
Tyr 4 8 5 
His 3 2 3 
Met 1 4 2 
Trp n.d. 2 1 
Calculated values were obtained from [19] and [5] assuming an 
M, of 25263 
plained by differences in the degree of purification 
or by using different producer strains for protein 
B production. 
Protein B contains 25% charged residues and 
has a net charge of +2.5 assuming that histidine 
carriers a charge of +0.5 [20]. The polarity index 
according to Vanderkooi and Capaldi [21] is 50%, 
which is close to the mean value of soluble proteins 
(46 * 6%). The hydrophobic residues are 
distributed equally throughout the protein. This is 
also documented by the hydrophobicity profile 
(fig.2) which shows the absence of pronounced 
hydrophobic domains. The sequence data reported 
here do not support the view that the 9 kDa CNBr 
fragment (pos. 22-107) in contrast to the 13.5 kDa 
CNBr fragment (pos. 108-226) may represent he 
‘membrane-binding domain’ of protein B [22]. Ex- 
tended hydrophobic regions, possibly responsible 
for membrane binding, have not yet been detected 
in protein B and were also found to be absent in 
other bacterial cytolytic toxins [23,24]. However, 
hydrophobic domains may result from protein 
folding in a way not predictable from sequence 
data. On the other hand binding of the above men- 
tioned membrane damaging proteins to a target 
may be mediated by restricted hydrophobic regions 
not clustered in an individual domain. The Fc- 
binding regions of proteins A and G consist of 
several extended repeating sequences. Protein A 
contains five homologous Fc-binding domains 
with sizes ranging from 50 to 61 amino acids [25], 
whereas protein G contains two or three 
homologous Fc-binding domains, each with a size 
of 55 amino acids [17,26]. Although the Fc- 
binding domains of these proteins are approx- 
imately of the same size, sequence comparison 
does not reveal any homology. 
In contrast to the extended repeats (50-61 amino 
acids) found in proteins A and G, protein B con- 
tains two repeating sequences of 5 and 11 amino 
acids only. 
48Val-Asn-Glu-Ala-11e-Thr 
79Val-. . . . 
__~ . . . ~ 
-Glu-Ale-Leu-Thr 
85Val-Ile-Glu-Ala-11e-Thr 
‘58Thr-Lys-Ser-Lys-Leu-Asp-Lys-Gln-Ile-Trp-Asn ~ . . . . . . . . ~ 
169Thr-Arg-Phe-Thr-Arg-Asp-Lys-Lys-V_al-Leu-Asn __ . . 
180Val-Lys-Glu-Phe-Lys-Val-Tyr-Asn-Thr-Leu-Asn 
Fig. 2. Hydrophobicity analysis of protein B using the HYDROP program (see text). Hydrophobic regions appear as positive peaks 
of hydropathicity. 
264 
Volume 235, number 1,2 FEBS LETTERS August 1988 
PROTEIN B (DOS. 129-173) 
PROTEIN A (DOS. 179-222) 
PROTEIN B (~0s. 174-217) 
PROTEIN A (~0s. 223-267) 
Fig. 3. Comparison of partial sequences of proteins B and A. Identical residues in both sequences have been boxed, conservative 
replacements have been marked with asterisks (*). Two gaps have been introduced for better alignment. 
However, it is not yet known whether the repeats 
in protein B are of any importance for Fc binding. 
The complete amino acid sequence of protein B 
was compared with the sequences of the Fc- 
binding domains of proteins A and G in order to 
identify regions which may be responsible for Fc 
binding of protein B. According to the statistical 
analysis (program ALIGN [18]) no homology has 
been found between protein B and the Fc-binding 
domains of protein G. However, comparison of a 
partial sequence of protein B (pos. 129-217) with 
a segment of the Fc-binding domain of protein A 
(pos. 179-267) [16] revealed 22 identical residues 
and 10 conservative replacements. For this com- 
parison two gaps were introduced for better align- 
ment (fig.3). The 89-residue string of protein B 
(pos. 129-217), which exhibits 36% homology with 
segment 179-267 of protein A, is located in the 
13,5 kDa CNBr fragment. This 13.5 kDa peptide 
has been shown to bind to immunoglobulins 
whereas no binding was found with the 9 kDa 
CNBR fragment [27]. Although sequence homo- 
logy between the Fc-binding region of protein A 
and protein B exists it is unclear as yet whether the 
same set of amino acids is responsible for binding 
1281. 
Protein B is an extracellular protein and released 
into the medium during mid to late logarithmic 
growth phase [ 111. In contrast proteins A and G re- 
main cell wall associated, but can be released by 
treatment with proteases [9,29]. Cell wall attach- 
ment of proteins A and G is supposed to be 
mediated by a hydrophobic C-terminal sequence, 
which is preceded by an extremely hydrophilic 
proline-rich region. These ‘membrane anchor se- 
quences’ of proteins A and G as well as the C- 
terminal sequence of streptococcal M 6 protein, 
which is also cell wall associated, exhibit a high 
degree of homology [17]. As anticipated for pro- 
tein B which is released into the medium a com- 
parable anchor sequence has not been found. 
Thus, the most important structural differences 
between protein B and proteins A and G are the 
absence of extended internal repeats and the lack 
of a membrane anchor sequence. Furthermore, 
protein B has been characterized as a protein active 
in synergistic hemolysis [4-61, a function which is 
not present in either protein A or G. 
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